2,899
Views
0
CrossRef citations to date
0
Altmetric
RSV

Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States

, , , , , & show all
Article: 2303796 | Received 06 Oct 2023, Accepted 07 Jan 2024, Published online: 31 Jan 2024

References

  • Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–10. doi:10.1056/NEJMoa043951.
  • Centers for Disease Control and Prevention. People at high risk for severe RSV infection. [accessed 2022 Aug 1]. https://www.cdc.gov/rsv/high-risk/index.html.
  • Centers for Disease Control and Prevention. RSV in older adults and adults with chronic medical conditions. [accessed 2022 Dec 1]. https://www.cdc.gov/rsv/high-risk/older-adults.html.
  • Havers FP, Whitaker M, Melgar M, Chatwani B, Chai SJ, Alden NB, Meek J, Openo KP, Ryan PA, Kim S. et al. Characteristics and outcomes among adults aged ≥60 years hospitalized with laboratory-confirmed respiratory syncytial virus — RSV-NET, 12 states, July 2022–June 2023. Am J Transplant. 2023;23:2000–7. doi:10.1016/j.ajt.2023.10.010.
  • Branche AR, Saiman L, Walsh EE, Falsey AR, Sieling WD, Greendyke W, Peterson DR, Vargas CY, Phillips M, Finelli L. Incidence of respiratory syncytial virus infection among hospitalized adults, 2017–2020. Clin Infect Dis. 2022;74:1004–11. doi:10.1093/cid/ciab595.
  • Ackerson B, Tseng HF, Sy LS, Solano Z, Slezak J, Luo Y, Fischetti CA, Shinde V. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69:197–203. doi:10.1093/cid/ciy991.
  • Begley KM, Monto AS, Lamerato LE, Malani AN, Lauring AS, Talbot HK, Gaglani M, McNeal T, Silveira FP, Zimmerman RK, et al. Comparisons of respiratory syncytial virus (RSV) and influenza: population characteristics and clinical outcomes in hospitalized adults. medRxiv. 2022: 2022.11.04.22281243.
  • Allen KE, Beekmann SE, Polgreen P, Poser S, St PJ, Santibañez S, Gerber SI, Kim L. Survey of diagnostic testing for respiratory syncytial virus (RSV) in adults: infectious disease physician practices and implications for burden estimates. Diagn Microbiol Infect Dis. 2018;92:206–9. doi:10.1016/j.diagmicrobio.2017.12.011.
  • Hurley LP, Allison MA, Kim L, O’Leary ST, Crane LA, Brtnikova M, Beaty BL, Allen KE, Poser S, Lindley MC. et al. Primary care physicians’ perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults. Vaccine. 2019;37(4):565–70. doi:10.1016/j.vaccine.2018.12.031.
  • National CfIH. RSV awareness: a national poll of parents & health care providers. [accessed 2022 Apr 1]. https://static1.squarespace.com/static/5523fcf7e4b0fef011e668e6/t/5bd1092b15fcc038c1f7cc1e/1540426027979/NCfIH_RSV+Survey+Results_Oct+2018.pdf.
  • Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, Heath PT, Khalil A, Finn A, Snape MD. et al. Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: a multicenter questionnaire study. Pediatr Infect Dis J. 2019;38(9):944–51. doi:10.1097/INF.0000000000002384.
  • Cals JW, Boumans D, Lardinois RJ, Gonzales R, Hopstaken RM, Butler CC, Dinant G-J. Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study. Br J Gen Pract. 2007;57:942–7. doi:10.3399/096016407782605027.
  • Filipetto FA, Modi DS, Weiss LB, Ciervo CA. Patient knowledge and perception of upper respiratory infections, antibiotic indications and resistance. Patient Prefer Adher. 2008;2:35–9.
  • Billard MN, Bont LJ. Quantifying the RSV immunity debt following COVID-19: a public health matter. Lancet Infect Dis. 2023;23(1):3–5. doi:10.1016/S1473-3099(22)00544-8.
  • Binns E, Koenraads M, Hristeva L, Flamant A, Baier-Grabner S, Loi M, Lempainen J, Osterheld E, Ramly B, Chakakala‐Chaziya J. et al. Influenza and respiratory syncytial virus during the COVID-19 pandemic: time for a new paradigm? Pediatr Pulmonol. 2022;57(1):38–42. doi:10.1002/ppul.25719.
  • Falsey AR, Cameron A, Branche AR, Walsh EE. Perturbations in respiratory syncytial virus activity during the SARS-CoV-2 pandemic. J Infect Dis. 2022;227(1):83–6. doi:10.1093/infdis/jiac434.
  • de Perio MA, Wiegand DM, Evans SM. Low influenza vaccination rates among child care workers in the United States: assessing knowledge, attitudes, and behaviors. J Commun Health. 2012;37:272–81. doi:10.1007/s10900-011-9478-z.
  • King JP, Hanson KE, Donahue JG, Glanz JM, Klein NP, Naleway AL, DeStefano F, Weintraub E, Belongia EA. Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016–17 season. Vaccine. 2020;38:2202–8. doi:10.1016/j.vaccine.2020.01.039.
  • Onwuchekwa C, Moreo LM, Menon S, Machado B, Curcio D, Kalina W, Atwell JE, Gessner BD, Siapka M, Agarwal N. et al. Under-ascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis. J Infect Dis. 2023;228(2):173–84. doi:10.1093/infdis/jiad012.
  • Rozenbaum MH, Judy J, Tran D, Yacisin K, Kurosky SK, Begier E. Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States. Infect Dis Ther. 2023;12:677–85. doi:10.1007/s40121-023-00758-5.
  • Schumacher S, Sparks G, Presiado M, Kirzinger A, Brodie M. KFF COVID-19 vaccine monitor: January 2023. [accessed 2023 Mar 20]. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-january-2023/.
  • Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D. et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98. doi:10.1056/NEJMoa0804877.
  • Centers for Disease Control and Prevention. RSV-NET interactive dashboard. [accessed 2023 Mar 21]. https://www.cdc.gov/rsv/research/rsv-net/dashboard.html.